postsynaptic density protein 95 (psd95) Search Results


psd 95  (Alomone Labs)
93
Alomone Labs psd 95
Psd 95, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psd 95/product/Alomone Labs
Average 93 stars, based on 1 article reviews
psd 95 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
psd 95  (StressMarq)
91
StressMarq psd 95
Psd 95, supplied by StressMarq, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psd 95/product/StressMarq
Average 91 stars, based on 1 article reviews
psd 95 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
psd 95  (Rockland Immunochemicals)
94
Rockland Immunochemicals psd 95
Psd 95, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psd 95/product/Rockland Immunochemicals
Average 94 stars, based on 1 article reviews
psd 95 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
psd 95 antibody  (Boster Bio)
93
Boster Bio psd 95 antibody
Psd 95 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psd 95 antibody/product/Boster Bio
Average 93 stars, based on 1 article reviews
psd 95 antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
rabbit anti postsynaptic dense substance 95 psd 95  (Boster Bio)
93
Boster Bio rabbit anti postsynaptic dense substance 95 psd 95
Rabbit Anti Postsynaptic Dense Substance 95 Psd 95, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti postsynaptic dense substance 95 psd 95/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti postsynaptic dense substance 95 psd 95 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
anti psd 95  (Alomone Labs)
94
Alomone Labs anti psd 95
Anti Psd 95, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti psd 95/product/Alomone Labs
Average 94 stars, based on 1 article reviews
anti psd 95 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
rabbit antipsd95 antibody  (Boster Bio)
93
Boster Bio rabbit antipsd95 antibody
Rabbit Antipsd95 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit antipsd95 antibody/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit antipsd95 antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
postsynaptic density protein 95 (psd95  (Cloud-Clone corp)
90
Cloud-Clone corp postsynaptic density protein 95 (psd95
Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density <t>protein</t> <t>95</t> <t>[PSD95;</t> ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).
Postsynaptic Density Protein 95 (Psd95, supplied by Cloud-Clone corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postsynaptic density protein 95 (psd95/product/Cloud-Clone corp
Average 90 stars, based on 1 article reviews
postsynaptic density protein 95 (psd95 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
postsynaptic density protein-95 (psd-95, msd #k250qnd)  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC postsynaptic density protein-95 (psd-95, msd #k250qnd)
Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density <t>protein</t> <t>95</t> <t>[PSD95;</t> ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).
Postsynaptic Density Protein 95 (Psd 95, Msd #K250qnd), supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postsynaptic density protein-95 (psd-95, msd #k250qnd)/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
postsynaptic density protein-95 (psd-95, msd #k250qnd) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
rabbit anti postsynaptic density protein 95  (Boster Bio)
93
Boster Bio rabbit anti postsynaptic density protein 95
Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density <t>protein</t> <t>95</t> <t>[PSD95;</t> ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).
Rabbit Anti Postsynaptic Density Protein 95, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti postsynaptic density protein 95/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti postsynaptic density protein 95 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
psd 95 mouse  (ProSci Incorporated)
90
ProSci Incorporated psd 95 mouse
Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density <t>protein</t> <t>95</t> <t>[PSD95;</t> ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).
Psd 95 Mouse, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psd 95 mouse/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
psd 95 mouse - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
postsynaptic density protein 95 (psd95)  (StemCells Inc)
90
StemCells Inc postsynaptic density protein 95 (psd95)
Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density <t>protein</t> <t>95</t> <t>[PSD95;</t> ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).
Postsynaptic Density Protein 95 (Psd95), supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postsynaptic density protein 95 (psd95)/product/StemCells Inc
Average 90 stars, based on 1 article reviews
postsynaptic density protein 95 (psd95) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density protein 95 [PSD95; ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).

Journal: Frontiers in Neuroscience

Article Title: Subcommissural Organ-Spondin-Derived Peptide Restores Memory in a Mouse Model of Alzheimer’s Disease

doi: 10.3389/fnins.2021.651094

Figure Lengend Snippet: Early stage daily treatment with NX210 or NX210c reduces pathological hallmarks of Alzheimer’s disease. Mice were treated intraperitoneally once a day with vehicle, NX210 or NX210c (2 mg/kg), or orally with donepezil (DPZ, 1 mg/kg) one hour after intracerebroventricular injection of scrambled control peptides (Ctrl) or amyloid-beta 25 – 35 (Aβ 25 – 35 ) oligomers. They were sacrificed at day 11 (D11) and cerebral structures [hippocampi (A–D) and prefrontal cortices (E–H) ] were collected for biochemical analyses of levels of Aβ 1 – 42 ( A ; ELISA), phosphorylated-tau on threonine 181 [pTau; ( B ; ELISA)], tumor necrosis factor-α [TNFα; ( C ; ELISA)], lipid peroxidation [LPO; ( D; measure of cumene hydroperoxide (CHP) absorbance)], glial fibrillary acidic protein [GFAP; ( E ; ELISA)], caspase-12 [Casp-12; ( F ; ELISA)], synaptophysin [SYP; ( G ; ELISA)] and postsynaptic density protein 95 [PSD95; ( H ; ELISA)]. NX210 and NX210c decreased the levels of all those pathological hallmarks of AD and increased synaptogenesis. The data are expressed in CHP equivalents (CHPeq) per wet weight of tissue (D) or in pg per mg of tissue ( other items ) and presented as means and SEM. One-way ANOVA followed by Tukey’s multiple comparisons test: ### p < 0.001, # p < 0.05 compared with Ctrl; *** p < 0.001, ** p < 0.01 comp ared with Aβ 25 – 35 ; £££ p < 0.001, £ p < 0.05 compared with Aβ 25 – 35 + DPZ; $$$ p < 0.001 Aβ 25 – 35 + NX210 vs. Aβ 25 – 35 + NX210c, n = 6 Ctrl, n = 5 Aβ 25 – 35 , Aβ 25 – 35 + DPZ, Aβ 25 – 35 + NX210c, n = 4 Aβ 25 – 35 + NX210. These analyses do not include two outliers identified for caspase 12 ELISA using the Grubbs test (red circles) ( p < 0.05).

Article Snippet: Based on the manufacturers’ instructions, ELISA for mouse amyloid-beta 1 – 42 (Aβ 1 – 42 ; Cloud-Clone Corp., Houston, TX, United States), phosphorylated-tau on threonine 181 (pTau; Thermo Fisher, Waltham, MA, United States), tumor necrosis factor alpha (TNF-α; Thermo Fisher) (from left hippocampi), glial fibrillary acidic protein (GFAP; Cloud-Clone Corp.), caspase-12 (Cloud-Clone Corp.) (from left prefrontal cortices), synaptophysin (Cloud-Clone Corp.) and postsynaptic density protein 95 (PSD95; Cloud-Clone Corp.) (from right prefrontal cortices) were performed.

Techniques: Injection, Enzyme-linked Immunosorbent Assay